NPI: 1912521568 · SAN DIEGO, CA 92121 · Clinical Medical Laboratory · NPI assigned 05/29/2020
| Authorized Official | BOBULSKY, SARAH (CFO) |
| NPI Enumeration Date | 05/29/2020 |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 26,168 | $1.48M |
| 2021 | 342,865 | $11.63M |
| 2022 | 255,072 | $9.36M |
| 2023 | 5,028 | $234K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 387,906 | 330,926 | $20.36M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 241,227 | 202,390 | $2.34M |